105 related articles for article (PubMed ID: 3148534)
1. [Metabolically neutral therapy of hypertension. An open, multicenter, prospective long-term study of the tolerance, safety and effectiveness of urapidil].
Liebau H; Wurst W; Harder I; Solleder P
Fortschr Med; 1988 Nov; 106(32):651-4. PubMed ID: 3148534
[No Abstract] [Full Text] [Related]
2. [Long-term antihypertensive therapy with urapidil. A 3-year open, multicenter trial of tolerance, safety and effectiveness].
Liebau H; Solleder P; Harder I; Wurst W
Fortschr Med; 1990 May; 108(16):325-8. PubMed ID: 2118878
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of hypertension with alpha blockade or ACE inhibition. Multicenter double-blind study of urapidil versus captopril].
Rosenthal J; Haerlin R
Fortschr Med; 1986 Oct; 104(40):763-6. PubMed ID: 3536700
[No Abstract] [Full Text] [Related]
4. [Treatment of hypertension with urapidil].
Fetkovská N; Dzúrik R
Cas Lek Cesk; 1985 Oct; 124(41-42):1292-5. PubMed ID: 3902242
[No Abstract] [Full Text] [Related]
5. [Urapidil in primary arterial hypertension].
Román O; Sudy E; Gac JC; Valenzuela MA
Rev Med Chil; 1987 Jul; 115(7):648-54. PubMed ID: 3331026
[No Abstract] [Full Text] [Related]
6. [Treatment of hypertensive crisis with ebrantil (urapidil)].
Mleczko-Nycz Z; Kokot F
Wiad Lek; 1984 Jun; 37(11):817-20. PubMed ID: 6390979
[No Abstract] [Full Text] [Related]
7. [Clinical trials of urapidil. Review of human pharmacological studies with a summary of a multi-center study].
Bruckschen EG; Henze F; Michael G
Arzneimittelforschung; 1978; 28(7):1176-84. PubMed ID: 385007
[No Abstract] [Full Text] [Related]
8. Urapidil compared with diuretics in the treatment of mild-to-moderate essential hypertensive patients: effects on glucose metabolism, insulin sensitivity, and lipid profile.
De Lima MD; Kohlmann NE; Neves FA; Zanella MT; Ribeiro AB; Kohlmann O
Blood Press Suppl; 1994; 4():53-6. PubMed ID: 7804514
[TBL] [Abstract][Full Text] [Related]
9. [Comparative clinical study of the antihypertensive effects of urapidil versus diazoxide in patients with severe arterial hypertension].
Gasparović V; Vrhovac B; Rumboldt Z; Ivanković D
Lijec Vjesn; 1986; 108(11-12):494-6. PubMed ID: 3553816
[No Abstract] [Full Text] [Related]
10. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
Zanchetti A
Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hypertension in the elderly with special reference to urapidil.
Hansson L
Blood Press Suppl; 1994; 4():45-8. PubMed ID: 7804512
[TBL] [Abstract][Full Text] [Related]
12. [Urapidil as a basic drug in severe hypertension].
Thuma G
Fortschr Med; 1986 Jun; 104(22):457-460. PubMed ID: 3744250
[No Abstract] [Full Text] [Related]
13. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
Schäfer N; Knaup G
Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
[No Abstract] [Full Text] [Related]
14. Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil.
Wacker JR; Wagner BK; Briese V; Schauf B; Heilmann L; Bartz C; Hopp H
Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):160-5. PubMed ID: 16253414
[TBL] [Abstract][Full Text] [Related]
15. [Ambulatory long-term blood pressure determination improves therapy of hypertension].
Lüders S; Züchner C; Schrandt G; Herbold M; Schrader J
MMW Fortschr Med; 1999 Jul; 141(28-29):40-2. PubMed ID: 10897942
[No Abstract] [Full Text] [Related]
16. Potential beneficial effects of urapidil in primary and secondary prevention of stroke.
Späh F; Walsemann SO
Blood Press Suppl; 1995; 3():62-7. PubMed ID: 8535545
[TBL] [Abstract][Full Text] [Related]
17. A preliminary report on the clinical evaluation of a new antihypertensive--GO. 1507--CIBA.
Billimoria AR; Shah SJ; Mehta AJ; Anand MP; Kumar H
Indian Heart J; 1968 Oct; 20(4):406-22. PubMed ID: 4906150
[No Abstract] [Full Text] [Related]
18. [Metabolic and cardiovascular profile in antihypertensive treatment with urapidil].
Gerber A; Weidmann P; Marone C; Uehlinger D; Riesen W
Therapie; 1990; 45 Suppl 2():219-27. PubMed ID: 2187268
[No Abstract] [Full Text] [Related]
19. Urapidil in hypercholesterolemic hypertensive patients.
Ferrara LA; Leonetti G; Fogari R; Mazzola C; Mancini M; Zanchetti A
Blood Press Suppl; 1994; 4():39-44. PubMed ID: 7804511
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
